bpc-157 safety human trials studies review Orthopedic Use of BPC-157 BPC-157: Experimental Peptide Creates Risk

Research suggests BPC-157 may support healing in muscles, tendons, ligaments, and bones

Patients returning to activities they had been avoiding due to pain or limited function

But the reality is these substances remain experimental for good reason

1 In simple language: BPC-157 is a short, laboratory-produced peptide with a defined 15-residue sequence

At baseline and at weeks 8 and 12, a clinician should assess fasting insulin and HOMA-IR (the homeostasis model assessment of insulin resistance, a calculated index derived from fasting glucose and insulin), HbA1c, high-sensitivity C-reactive protein as an inflammatory marker, and body composition by DEXA scan or bioelectrical impedance

The peptide shows potential neuroprotective properties